Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
  • Partner programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • TEST DRAFT PAGE
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Expanding access to hepatitis C prevention, testing, and treatment in prisons
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
    • Search resources
  • Elimination champions
  • News
    • Announcements
    • News search
    • HepEquity Blog
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
  • Webinars & Events
    • HCV in Prisons
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
      • Webinar 3: Recommendations
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • Search webinars
  • UN Group of Friends
  1. Home
  2. Partner programs
  3. Programs search

Programs search

Filter

  • Active
  • Hepatitis B
  • Hepatitis C
  • Adolescents (10 - 19 years of age)
  • Adults
  • Adults (> 19 years of age)
  • All ages
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Children (> one year < 10 years of age)
  • Children 5-11
  • Children 12-17
  • Children Under 5
  • General Population
  • Household contact(s)
  • Incarcerated populations (current and former)
  • Infants (less than one year of age)
  • (-) Men who have sex with men
  • Newborn (born in last 30 days)
  • Newborns
  • Not yet known
  • Occupations with possible exposure
  • People experiencing homelessness
  • Persons who inject drugs
  • Persons with substance use disorder
  • Pregnant women
  • Sexual contact(s)
  • Young Adults <21
  • Global
  • Micro elimination
  • National
  • Blood safety
  • Coinfection with HIV
  • Community mobilization
  • Harm reduction
  • HBV perinatal screening and prophylaxis
  • (-) HBV testing and linkage to care
  • HCV testing and linkage to Care
  • HCV treatment
  • Hepatitis B Vaccination
  • Hep B birth-dose vaccination
  • Implementation of birth dose vaccination
  • Implementation of vaccination (general)
  • Injection safety and infection control
  • Linkage to care
  • Persons who inject drugs: HCV cure as prevention
  • Persons who inject drugs: Medication assisted therapy
  • Persons who inject drugs: Syringe service program(s)
  • Prevention mother-child transmission
  • Program evaluation
  • Prophylaxis
  • Safer injection practices
  • Safer sex practices
  • Screening and diagnosis
  • Screening of pregnant women
  • Strategic data analysis
  • Testing
  • Treatment
  • Treatment (direct or referral)
  • Vaccination (general)
  • Georgia
  • Global
  • Indonesia
  • Uganda
  • United States of America

Displaying 1 - 5 of 5

  • Hep Free S-W Organization

    African Region
    Hepatitis B
    Hepatitis C
  • Flag of Georgia

    Georgia National HCV Elimination Program

    European Region
    Hepatitis B
    Hepatitis C
  • Bali Peduli clinic sign

    Bali Peduli -- Indonesia

    Western Pacific Region
    Hepatitis B
    Hepatitis C
  • AASLD logo

    American Association for the Study of Liver Diseases - United States

    Region of the Americas
    Hepatitis B
    Hepatitis C
  • Logo

    Coalition for Global Hepatitis Elimination

    African Region
    Eastern Mediterranean Region
    European Region
    Region of the Americas
    South-East Asia Region
    Hepatitis B
    Hepatitis C

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media